Journal home
Advance online publication
Current issue
Archive
Press releases
Free Association (blog)
Supplements
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
 
NPG Resources
Nature
Nature Biotechnology
Nature Cell Biology
Nature Medicine
Nature Methods
Nature Reviews Cancer
Nature Reviews Genetics
Nature Reviews Molecular Cell Biology
news@nature.com
Nature Conferences
RNAi Gateway
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Letter
Nature Genetics  12, 333 - 337 (1996)
doi:10.1038/ng0396-333

The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds

S.V. Tavtigian1, J. Simard2, J. Rommens3, F. Couch4, D. Shattuck-Eidens1, S. Neuhausen5, S. Merajver6, S. Thorlacius7, K. Offit8, D. Stoppa-Lyonnet9, C. Belanger2, R. Bell1, S. Berry1, R. Bogden1, Q. Chen1, T. Davis1, M. Dumont2, C. Frye1, T. Hattier1, S. Jammulapati1, T. Janecki1, P. Jiang1, R. Kehrer1, J.-F. Leblanc2, J.T. Mitchell1, J. McArthur-Morrison3, K. Nguyen5, Y. Peng4, C. Samson2, M. Schroeder1, S.C. Snyder3, L. Steele5, M. Stringfellow1, C. Stroup1, B. Swedlund1, J. Swense5, D. Teng1, A. Thomas1, T. Tran5, M. Tranchant2, J. Weaver-Feldhaus1, A.K.C. Wong1, H. Shizuya10, J.E. Eyfjord7, L. Cannon-Albright5, M. Tranchant2, F. Labrie2, M.H. Skolnick1, 5, B. Weber4, A. Kamb1 & D.E. Goldgar5, 11

  1Myriad Genetics Inc., Salt Lake City, Utah USA.

  2Laboratory of Molecular Endocrinology, CHUL Research Center and Laval University, Quebec City, Canada.

  3Department of Genetics, Hospital for Sick Children, University of Toronto, Ontario, Canada.

  4Deparment of Hematology-Oncology, University of Pennsylvania, Philadelphia, USA.

  5Genetic Epidemiology Group, Department of Medical Informatics and Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA

  6 Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA.

  7Molecular and Cell Biology Research Laboratory, Icelandic Cancer Society, Rekjavik, Iceland.

  8Department of Human Genetics, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.

  9Unite de Genetique Oncologique, Institute Curie, Paris, France.

  10Division of Biology, California Institute of Technology, Pasadena, California, USA.

  11Unit of Genetic Epidemiology, International Agency for Research on Cancer, 150 cours Albert Thomas, 63972, Lyon, Cedex08, France.

 Correspondence should be addressed to D.E.G.

Breast carcinoma is the most common malignancy among women in developed countries. Because family history remains the strongest single predictor of breast cancer risk, attention has focused on the role of highly penetrant, dominantly inherited genes in cancer-prone kindreds1. BRCA1 was localized to chromosome 17 through analysis of a set of high-risk kindreds2, and then identified four years later by a positional cloning strategy3. BRCA2 was mapped to chromosomal 13q at about the same time4. Just fifteen months later, Wooster et al.5 reported a partial BRCA2 sequence and six mutations predicted to cause truncation of the BRCA2 protein. While these findings provide strong evidence that the identified gene corresponds to BRCA2, only two thirds of the coding sequence and 8 out of 27 exons were isolated and screened; consequently, several questions remained unanswered regarding the nature of BRCA2 and the frequency of mutations in 13q-linked families. We have now determined the complete coding sequence and exonic structure of BRCA2 (GenBank accession sharpU43746), and examined its pattern of expression. Here, we provide sequences for a set of PCR primers sufficient to screen the entire coding sequence of BRCA2 using genomic DMA. We also report a mutational analysis of BRCA2 in families selected on the basis of linkage analysis and/or the presence of one or more cases of male breast cancer. Together with the specific mutations described previously, our data provide preliminary insight into the BRCA2 mutation profile.


REFERENCES
  1. Kelsey, J.L. & Gammon, M.D. The epidemiology of breast cancer. CA Cancer J. Clinic. 41, 147−165 (1991).
  2. Hall, J.M. et al. Linkage of early-onset familial breast cancer to chromosome 17q21. Science. 250, 1684−1689 (1990). | PubMed  | ISI | ChemPort |
  3. Miki, Y. et al. A strong candidated for the 17q-linked breast and ovarian cancer susceptibility gene BRCA1. Science. 266, 66−71 (1994). | PubMed  | ISI | ChemPort |
  4. Wooster, R. et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science. 265, 2088−2090 (1994). | PubMed  | ISI | ChemPort |
  5. Wooster, R. et al. Identification of the breast cancer gene BRCA2. Nature. 378, 789−791 (1995). | Article | PubMed  | ISI | ChemPort |
  6. Schutte, M. et al. Identification by representational difference analysis of a homozygous deletion in pancreatic carcinoma that lies within the BRCA2 region. Proc. Natl. Acad. Sci. USA. 92, 5950−5954 (1995). | PubMed  | ChemPort |
  7. Stone, S. et al.Complex structure and regulation of the P16 (MTS1) locus. Cancer Res. 55, 2988−2994 (1995). | PubMed  | ISI | ChemPort |
  8. Simard, J. et al. Generation of a transcription map of the BRCA2 region. Am. J. Hum. Genet. 57, (suppl) 1566 (1995). | ISI |
  9. Friedman, L.S. et al. Novel inherited mutations and variable expressivity of BRCA1 alleles including the founder mutation 185 del AG in Ashkenazi Jewish families. Am. J. Hum. Genet. 57, 1284−1297 (1995). | PubMed  | ISI | ChemPort |
  10. Szabo, C.I. & King, M.-C. Inherited breast and ovarian cancer. Hum. Mol.Genef. 4, 1811−1817 (1995). | ChemPort |
  11. Shattuck-Eidens, D. et al. A comparative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene: Implication for presymptomatic testing and screening. JAMA. 273, 535−541 (1995). | Article | PubMed  | ChemPort |
  12. Parimoo, S. et al. cDNA selection: Efficient PCR approach for the selection of cDNAs encoded in large chromosomal DNA fragments. Proc. Natl. Acad. Sci. USA. 88, 9623−9627 (1991). | PubMed  | ChemPort |
  13. Rommens, J.M. et al. Towards a transcriptional map of the q21 -q22 region of chromosome 7. In 'Identification of transcribed sequences', (eds Hochgeschwender, U. & Gardiner, K.) pp. 65−79 (Plenum Press, New York, 1994). | ChemPort |
  14. Lovett, M., Kere, J. Direct selection: A method for the isolation of cDNAs encoded by large genomic regions. Proc. Natl. Acad. Sci. USA. 88, 9628−9632 (1991). | PubMed  | ChemPort |
  15. Nattier, T. et al. Analysis of hybrid selection in the search for BRCA1. Mamm. Genome 6, 873−879 (1995). | PubMed  |
  16. Church, D.M. et al. Identification of human chromosome 9 specific genes using exon amplification. Hum. Mol. Genet. 2, 1915 (1993). | PubMed  | ISI | ChemPort |
  17. Kamb, A. et al. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nature Genet. 8, 22−29 (1994). | ISI | ChemPort |
 Top
 Top
References
Previous | Next
Table of contents
Download PDFDownload PDF
Send to a friendSend to a friend
Save this linkSave this link

natureevents

References
Export citation
Export references
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Genetics
ISSN: 1061-4036
EISSN: 1546-1718
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | For authors | Online submission | Permissions | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | naturereprints | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©1996 Nature Publishing Group | Privacy policy